Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: hot flashes, dementia, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, May 27 - Friday, May 31 2024), and click each link to read and watch anything you may have missed.
1.) Study links acute physical activity increases to hot flashes
New research reveals that acute increases in physical activity and ambient temperature can elevate the risk of both objective and subjective hot flashes in postmenopausal women.
Click here for the full article.
2.) Preeclampsia linked to elevated risk of young-onset dementia
Recent research reveals a correlation between preeclampsia and heightened risk of young-onset dementia, shedding light on potential long-term consequences of this pregnancy complication.
Click here for the full article.
3.) Similar delivery times between misoprostol dosages among obese patients reported
A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Click here for the full article.
4.) Major adverse pregnancy outcomes linked to long-term risk of kidney disease
A recent study highlighted the significant association between adverse pregnancy outcomes and an elevated long-term risk of chronic kidney disease, emphasizing the need for heightened awareness and monitoring.
Click here for the full article.
5.) Addressing maternal health inequities: Insights from CDC's Wanda Barfield
Wanda Barfield, MD, MPH, highlights significant racial disparities in maternal mortality and emphasizes the importance of collaborative efforts and data-driven approaches to improve maternal health outcomes in the United States.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
First patient dosed in trial evaluating fezolinetant for VMS in breast cancer patients
August 28th 2024Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.
Read More
Severe menopause symptoms linked to increased risk of cognitive decline in postmenopausal women
August 22nd 2024A significant connection has been identified between severe menopause symptoms and cognitive impairment in postmenopausal women, according to findings from a study published in Menopause, the journal of The Menopause Society.
Read More